The Orthobiologics Market in Europe is Estimated to Grow to Around $1565.3 Million by 2018 - New Report by MicroMarket Monitor

Share Article

The European orthobiologics report defines and segments the concerned market in Europe with analysis and forecast of revenue.http://www.micromarketmonitor.com/market/europe-orthobiologics-9908210168.html

MicroMarket Monitor

MicroMarket Monitor

Key Players in the European Orthobiologics market are Stryker, Zimmer, DePuy Synthes, Medtronic, Smith and Nephew, Exactech Inc., Tornier, Biomet Inc.

European Orthobiologics market is anticipated to spur due to rapidly aging population, and growing patient awareness.

Browse through the TOC of the European orthobiologics market, to get an idea of the in-depth analysis provided. This also provides glimpse of orthobiologics market segmentation in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/europe-orthobiologics-9908210168.html

The demand for orthopedic care and procedures is rising in the elderly population, therefore, European market for orthopedic devices is expected to significantly benefit from the rise in the region’s aging population. All the product segments of orthobiologics like bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation experienced a positive growth in 2013 with an increased demand for technological advances in bone graft materials.

This market will continue to witness high growth because of demand for innovative products and rise in prevalence of chronic arthritis, osteoarthritis and bone fracture, besides the aging population. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and sport injuries have augmented the growth in this market.

Speak to Analyst @

http://www.micromarketmonitor.com/contact/9908210168-speak_to_analyst.html

This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation. The market is further segmented and forecast on the basis of major countries, such as the Germany, France, U.K., Italy, and Spain. The market is also segmented and analyzed further on the basis of the end users.

Early buyers will receive 10% customization on this report.

http://www.micromarketmonitor.com/contact/9908210168-request_for_customization.html

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.

Related Reports :

North American Orthobiologics Market

Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in human body.

The North American Orthobiologics Market is mainly driven by innovation in implant technologies and shifting demand from mechanical to biological solutions. The report “North American Orthobiologics Market forecast, 2012-2018” analyzes the market of Orthobiologics industry by 6 product segments such as Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy and Visco-supplementation.

All of these segments experience a positive growth from 2012 with an increased demand for technological advances in bone graft materials. The markets have been witnessing the maximum growth because of demand for innovative products and Rising prevalence of chronic arthritis and rapidly aging world population.

http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html

Asian Orthobiologics Market

Orthobiologics has been gaining popularity as it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market.

Geographically, the Asian Orthobiologics Market is segmented into China, India, Japan and Rest of Asia.The high prevalence in Asia is because of maximum aging population and high diabetes and obese population.

http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
Micro Market Monitor
Like >
Visit website